WASHINGTON DC (May 1, 2020) — The US Food and Drug Administration included, under the ventilator Emergency-Use Authorization (EUA), a ventilator developed by the National Aeronautics and Space Administration (NASA), which is tailored to treat patients with COVID-19.

WASHINGTON DC (April 22, 2020) — The US Food and Drug Administration has authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued the emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test to permit testing of samples self-collected by patients at home using LabCorp’s Pixel by LabCorp COVID-19 Test home collection kit.

WASHINGTON DC (April 16, 2020) — As part of the all-of-America approach to fighting the COVID-19 pandemic, the US Food and Drug Administration has been working with partners across the US government, academia, and industry to expedite the development and availability of critical medical products to treat this novel virus.

WASHINGTON DC (April 15, 2020) — The COVID-19 pandemic has created challenges in our everyday lives. As we each do our part to help slow the spread of coronavirus disease, we look to the helpers all around us and wonder if we, too, could do more.

Here are some ways you and your family can help.